24/7 Market News Snapshot 01 April, 2025 – GRI Bio, Inc. Common Stock (NASDAQ:GRI)

April 1, 2025

DENVER, Colo., 01 April, 2025 (247marketnews.com) – (NASDAQ:GRI) are discussed in this article.
GRI Bio, Inc. (NASDAQ:GRI), a biotechnology firm focused on innovative treatments for inflammatory and autoimmune diseases, has recently experienced significant trading volatility, with the stock price opening at $9.33 and fluctuating to $4.745, representing a dramatic change of 48.28%. Following a previous close of $3.200, the heightened trading activity has generated substantial interest, as the company recorded a trading volume of 8.16 million shares, drawing the attention of market participants.

In addition to this market dynamism, GRI Bio has successfully priced a public offering consisting of 1,388,888 shares of its common stock alongside a series of warrants. Set at a combined price of $3.60 per share, this strategic initiative aims to bolster the company’s innovative pipeline centered on Natural Killer T (NKT) cell modulators, which have vital applications for critical health challenges faced by many individuals globally. The warrants associated with this offering provide an exercise price of $3.20 per share, enhancing potential returns for investors and encouraging deeper investment.

The anticipated gross proceeds from the public offering are approximately $5.0 million, which GRI Bio plans to utilize primarily for the advancement of its product candidates and to meet general working capital needs. Additionally, the full exercise of the warrants could yield nearly $13.3 million in further financing, underscoring investor confidence in GRI’s future prospects.

As GRI Bio continues to advance its lead therapeutic program, GRI-0621, which targets idiopathic pulmonary fibrosis—an area of substantial unmet medical need—it remains committed to transforming treatment paradigms within the biotechnology sector. With a robust pipeline and a clear focus on research and development, GRI Bio is well-positioned to make a significant impact on disease treatment and patient care.

Related news for (GRI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.